Upexi, Inc.UPXIReports Thu, Sep 17 · Fiscal Year 2026
Consumer Discretionary · Consumer Durables & Apparel · NASDAQ · United States · upexi.com
Upexi, Inc. is a brand owner engaged in the development, manufacturing, and distribution of consumer products including pet supplements under the LuckyTail brand, energy products under PRAX, functional mushrooms under Cure Mushrooms, and cannabinoid products under Moonwlkr. The company also maintains a significant cryptocurrency treasury strategy focused on Solana (SOL) and is headquartered in Tampa, Florida.
Key ratios
FCF / Sales
-71.9%TTM
2025
-55.7%2024
-4.0%2023
-2.0%
Net margin
264.3%TTM
2025
-86.6%2024
-91.0%2023
-46.5%
ROA
-49.9%TTM
2025
-10.8%2024
-19.2%2023
-9.5%
ROE
-468.5%TTM
2025
-28.3%2024
-147.1%2023
-56.9%
Revenue growth
32.8%TTM
2025
-39.2%2024
-28.7%2023
58.0%
Recent news
Upexi to Host Fiscal Year 2026 Earnings Call on Thursday, September 17th at 5:30 P.M. ET
Upexi Amends BitGo Credit Facility
Upexi to Participate in FT Partners FinTech Conference 2026 on September 15th
Upexi Added to the Russell Microcap® Index
Upexi, Inc. Announces Pricing of ~$19.5 Million Private Placement of Common Stock
Track UPXI in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer